The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...

Datar Cancer Genetics Inc., a global company developing blood-based diagnostics for cancer, has received the U.S. Food and Drug Administration’s breakthrough devices designation for TriNetra-Glio, the ...

Envoy Medical®, Inc. ("Envoy Medical") (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing devices, today ...

Patient Enrolled at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital Aethlon's Trial is a Safety, Feasibility, and Dose Finding Study of the Hemopurifier® ...

Detailed price information for Spectral Medical Inc (EDT-T) from The Globe and Mail including charting and trades.

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET. Company Participants. Matthew Kreps - Investor Relations Jeffrey Soinski - Chief Executiv ...

Boomerang Medical, a women-led bioelectronic medicine company, has been granted Breakthrough Device Designation from the Food and Drug Administration (FDA) for its bioelectronic technology ...

Johnson & Johnson announced that the U.S. Food and Drug Administration has granted nipocalimab Breakthrough Therapy designation for the ...

Vaxcyte (NASDAQ:PCVX) announced that the U.S. FDA cleared the VAX-31 infant Investigational New Drug application and granted ...

The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & ...

An innovative treatment for debilitating and often deadly cases of recurrent C diff infection has been given a Breakthrough Therapy Designation by the FDA. Developed by US biotech firm Rebiotix ...

The drug was developed and approved quickly after the FDA granted the drug Breakthrough Therapy Designation and Priority Review status. Pfizer and German Merck struck an alliance to develop ...